Giant Chinese vitamins in the judicial fight to continue claiming their fish oil capsules are Australian made

The nationally owned vitamins giant Nature's Care is fighting for the right to market its fish oil tablets and vitamin D, such as manufactured in Australia?

The nationally owned vitamins giant Nature & # 39; s Care is fighting for the right to market its fish oil tablets and vitamin D as "made in Australia".

Faced with the personality of the television Kerri-Anne Kennerley, the company has brought the Australian Competition and Consumption Commission (ACCC) before the courts after the introduction of more stringent country of origin labeling laws.

Nature's Care has a manufacturing plant in Sydney, but is financially controlled by two Chinese capital firms, located in Singapore and the Cayman Islands.

The company's fish oil and vitamin D tablets, marketed under its Healthy Care brand, comprise a mixture of imported active ingredients that are placed in capsules in Australia.

The ACCC has said that this process is unlikely to qualify as done in Australia because it is not a "substantial transformation" which makes a fundamental difference between the imported product and the final one.

However, if a company created a tablet or essential oil in Australia using raw imported ingredients, that product would be eligible for the & # 39; made in Australia & # 39;

The nationally owned vitamins giant Nature's Care is fighting for the right to market its fish oil tablets and vitamin D, such as manufactured in Australia?

The nationally owned vitamins giant Nature & # 39; s Care is fighting for the right to market its Fish Oil and Vitamin D tablets as made in Australia & # 39;

"The collection of raw ingredients, including fish oil, before encapsulation is fundamentally different in identity, nature and essential character of the finished product, being the soft gelatin capsule containing fish oil and vitamin D," said Nature & # 39; s Care in a federal court document obtained by News Corp.

The company also argued that "in any case … it is neither deceptive nor misleading to describe those goods as 'facts in Australia' given the encapsulation process that occurs in Australia.

In addition, he stated that if he was not allowed to market his product as manufactured in Australia, Nature's Care would lose its competitive advantage, in addition to incurring huge repacking costs.

Headed by Kerri-Anne Kennerley, Nature & # 39; s Care has led the Australian Competition and Consumer Commission before the courts following the introduction of stricter country of origin labeling laws last year.

Headed by Kerri-Anne Kennerley, Nature & # 39; s Care has led the Australian Competition and Consumer Commission before the courts following the introduction of stricter country of origin labeling laws last year.

Headed by Kerri-Anne Kennerley, Nature & # 39; s Care has led the Australian Competition and Consumer Commission before the courts following the introduction of stricter country of origin labeling laws last year.

According to The Courier Mail, Nature & # 39; s Care & 2017; s 2017 Financial Review showed a net profit of $ 37 million, an increase compared to 2016, mainly due to higher demand from Asia, especially China.

An ACCC spokeswoman told Daily Mail Australia that "as the matter is in court, we can not comment."

Daily Mail Australia has also contacted Nature & # 39; s Care for more comments.

The ACCC has said that the Nature & # 39; s Care process of encapsulating the tablets in Australia is "unlikely" to qualify as done in Australia because it is not a "substantial transformation" that makes a fundamental difference between the imported product and the product. final.

The ACCC has said that the Nature & # 39; s Care process of encapsulating the tablets in Australia is "unlikely" to qualify as done in Australia because it is not a "substantial transformation" that makes a fundamental difference between the imported product and the product. final.

The ACCC has said that the Nature & # 39; s Care process to encapsulate the tablets in Australia "is not likely" to qualify as done in Australia because it is not a "substantial transformation" that makes a fundamental difference between the imported product and the Final product.

.